Last year the Government put out a media release which sought to relieve the concerns of many if the ADF and ex-service community of the anti-malarial drug, Mefloquine. Their ability to deliver on this has been underwhelming.
An anti-malarial, once used in ADF drug trials and now used as a third-string prescription drug, Mefloquine has been used in the Australian Defence Force for defence personnel deploying to high-risk malarial environments.